Drug Trial Radar · NCT07216482
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
996
Actual
Start
Nov 11, 2025
Primary completion
Aug 3, 2026
Study completion Oct 27, 2026
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Oct 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Researchers designed a study medicine called enlicitide to lower low-density lipoprotein cholesterol (LDL-C). In this study, researchers want to learn about giving enlicitide with another medicine called rosuvastatin. Rosuvastatin is a standard (usual) treatment to lower LDL-C. The goal of this study is to learn if enlicitide given with rosuvastatin works better than placebo on lowering LDL-C in a person's blood. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of a study medicine.
Conditions
- Hyperlipidemia
Interventions
EnlicitideDrug
Oral Tablet
RosuvastatinDrug
Oral Capsule
Placebo for EnlicitideDrug
Oral Tablet
Placebo for RosuvastatinDrug
Oral Capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change from Baseline in LDL-C at Week 8 (Enlicitide + Rosuvastatin Versus Placebo)Time frame: Baseline and Week 8
Locations
87 sites in 11 countries. Site status is shown where the registry gives one.
Central Research Associates ( Site 0009)
Birmingham, Alabama
G&L Research ( Site 0024)
Foley, Alabama
Synexus Clinical Research US, Inc. - Phoenix Central ( Site 0030)
Phoenix, Arizona
Alliance for Multispecialty Research LLC ( Site 0049)
Tempe, Arizona
Chemidox Clinical Trials ( Site 0008)
Lancaster, California
Clinical Trials Research ( Site 0036)
Sacramento, California
Legacy Clinical Trials ( Site 0044)
Colorado Springs, Colorado
Alliance for Multispecialty Research, LLC ( Site 0040)
Fort Myers, Florida
Soffer Health Institute ( Site 0046)
Hollywood, Florida
East Coast Institute for Research ( Site 0041)
Lake City, Florida
Inpatient Research Clinic ( Site 0017)
Miami Lakes, Florida
Clinical Research Trials of Florida ( Site 0001)
Tampa, Florida
Clinical Site Partners LLC, dba CSP Orlando ( Site 0014)
Winter Park, Florida
Trialmed ( Site 0026)
Chicago, Illinois
Great Lakes Clinical Trials - Ravenswood ( Site 0018)
Chicago, Illinois
Midwest Institute For Clinical Research ( Site 0033)
Indianapolis, Indiana
Alliance for Multispecialty Research, LLC ( Site 0048)
Newton, Kansas
Cotton O'Neil Clinical Research Center ( Site 0006)
Topeka, Kansas
L-MARC Research Center ( Site 0004)
Louisville, Kentucky
Jubilee Clinical Research ( Site 0031)
Las Vegas, Nevada
Cardiovascular Associates of the Delaware Valley ( Site 0035)
Elmer, New Jersey
New Mexico Clinical Research & Osteoporosis Center, Inc. ( Site 0027)
Albuquerque, New Mexico
Alliance for Multispecialty Research, LLC - Norman ( Site 0043)
Norman, Oklahoma
Cardiology Consultants of Philadelphia Yardley ( Site 0016)
Yardley, Pennsylvania
Provecta Research Network LLC ( Site 0022)
Houston, Texas
Permian Research Foundation ( Site 0005)
Odessa, Texas
LinQ Research ( Site 0025)
Pearland, Texas
Clinical Trials of Texas, Inc. ( Site 0010)
San Antonio, Texas
Stone Oak, LLC dba Discovery Clinical Trials (DCT) ( Site 0021)
San Antonio, Texas
LinQ Research - Tomball ( Site 0047)
Tomball, Texas
Conquest Research ( Site 0045)
Arlington, Virginia
Manassas Clinical Research Center ( Site 0002)
Manassas, Virginia
Health Research of Hampton Roads, Inc. ( Site 0013)
Newport News, Virginia
National Clinical Research, Inc ( Site 0028)
Richmond, Virginia
Rainier Clinical Research ( Site 0023)
Renton, Washington
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada ( Site 0206)
CABA, Argentina
Instituto de Cardiología "Juana F. Cabral"-Cardiología ( Site 0205)
Corrientes, Argentina
CEMEDIC ( Site 0201)
CABA, Buenos Aires, Argentina
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0202)
Mar del Plata, Buenos Aires, Argentina
CIPREC-CIPREC Sede Arenales ( Site 0200)
Buenos Aires, Buenos Aires F.D., Argentina
Showing 40 of 87 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.